AMRZ
Amrize Ltd NYSE Listed Jun 23, 2025$53.46
Mkt Cap $29.5B
52w Low $44.12
42.8% of range
52w High $65.94
50d MA $57.12
200d MA $53.65
P/E (TTM)
24.9x
EV/EBITDA
12.0x
P/B
2.2x
Debt/Equity
0.5x
ROE
8.9%
P/FCF
21.1x
RSI (14)
—
ATR (14)
—
Beta
0.74
50d MA
$57.12
200d MA
$53.65
Avg Volume
3.4M
Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.
Grafenauweg 10 · Zug 6300 · CH
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 17, 2026 | AMC | 0.65 | 0.54 | -16.4% | 57.39 | +6.4% | +11.0% | +0.3% | +1.9% | -2.3% | +3.5% | — |
| Oct 28, 2025 | AMC | 1.02 | 1.06 | +3.9% | 50.44 | +4.7% | +4.8% | -1.7% | -0.3% | -1.4% | -0.3% | — |
| Aug 6, 2025 | AMC | 1.03 | 0.78 | -24.3% | 50.01 | -10.5% | -6.7% | +2.2% | -0.7% | +2.6% | +6.2% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 1 | Vertical Research | Upgrade | Hold → Buy | $70 | $53.78 | $54.85 | +2.0% | -0.7% | -4.6% | +4.8% | +3.0% | -2.7% |
| Apr 15 | Wells Fargo | Maintains | Overweight → Overweight | — | $59.96 | $59.93 | -0.1% | -2.1% | -2.6% | +0.9% | +0.9% | -1.9% |
| Mar 5 | JP Morgan | Maintains | Overweight → Overweight | — | $62.73 | $61.59 | -1.8% | -1.9% | -5.5% | +1.4% | +0.4% | -1.6% |
| Feb 20 | Truist | Maintains | Buy → Buy | — | $63.92 | $64.30 | +0.6% | +1.9% | -2.3% | +3.5% | -3.8% | +1.2% |
| Feb 19 | Oppenheimer | Maintains | Outperform → Outperform | — | $63.70 | $62.54 | -1.8% | +0.3% | +1.9% | -2.3% | +3.5% | -3.8% |
| Feb 19 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $63.70 | $62.54 | -1.8% | +0.3% | +1.9% | -2.3% | +3.5% | -3.8% |
| Feb 19 | Wells Fargo | Maintains | Overweight → Overweight | — | $63.70 | $62.54 | -1.8% | +0.3% | +1.9% | -2.3% | +3.5% | -3.8% |
| Jan 29 | Wells Fargo | Maintains | Overweight → Overweight | — | $53.64 | $53.94 | +0.6% | +1.0% | -2.8% | +0.6% | +2.0% | +4.0% |
| Jan 15 | Oppenheimer | Maintains | Outperform → Outperform | — | $54.60 | $54.87 | +0.5% | -0.1% | +0.0% | -2.9% | +1.3% | +2.2% |
| Jan 8 | UBS | Maintains | Neutral → Neutral | — | $54.44 | $53.17 | -2.3% | +1.5% | +3.7% | +0.7% | -2.2% | -3.3% |
| Jan 8 | Citigroup | Maintains | Buy → Buy | — | $54.44 | $53.17 | -2.3% | +1.5% | +3.7% | +0.7% | -2.2% | -3.3% |
| Dec 8 | RBC Capital | Downgrade | Outperform → Sector Perform | — | $54.74 | $54.76 | +0.0% | -2.6% | +0.3% | +1.9% | +3.3% | -0.1% |
| Nov 3 | Citigroup | Maintains | Buy → Buy | — | $51.84 | $50.85 | -1.9% | -1.4% | -0.3% | -0.3% | -2.2% | -0.6% |
| Nov 3 | UBS | Maintains | Neutral → Neutral | — | $51.84 | $50.85 | -1.9% | -1.4% | -0.3% | -0.3% | -2.2% | -0.6% |
| Oct 30 | Wells Fargo | Maintains | Overweight → Overweight | — | $52.85 | $52.42 | -0.8% | -1.7% | -0.3% | -1.4% | -0.3% | -0.3% |
| Oct 14 | UBS | Maintains | Neutral → Neutral | — | $47.62 | $47.68 | +0.1% | +3.0% | -1.2% | -0.3% | +0.5% | +0.4% |
| Aug 26 | JP Morgan | Maintains | Overweight → Overweight | — | $51.15 | $51.19 | +0.1% | +1.6% | +0.0% | +0.2% | -0.1% | +1.3% |
| Aug 8 | RBC Capital | Maintains | Outperform → Outperform | — | $46.65 | $46.65 | +0.0% | +2.2% | -0.7% | +2.6% | +6.2% | -0.2% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| May 5, 2026 | Clark Stephen SOff | Chief People Officer | Buy | 2 | $52.75 | $106 | 5,260 | -1.08% | — |
8-K
Amrize Ltd -- 8-K Filing
Amrize Ltd (AMRZ) restructured its Audit Committee with Newman replacing Robert Rivkin as chair while Jacques Wolf Sanche joins and Holli Ladhani departs, signaling potential governance changes.
Apr 21
8-K · 8.01
!! High
Unknown — 8-K 8.01: Material Event / Announcement
I cannot provide a meaningful analysis as this filing contains only technical metadata and schema references without actual business information or announcements about Amazon's operations, financials, or strategy.
Apr 14
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
GXO's CEO departure effective March 31, 2026, creates leadership uncertainty that could impact operational continuity and investor confidence until a successor is named.
Mar 31
8-K · 4.01
!!! Very High
Amrize Ltd -- 8-K 4.01: Auditor Change / Resignation
Amrize Ltd (AMRZ) replaced its auditor with Ernst & Young LLP, a change that may signal accounting concerns or represent a routine transition for investors to monitor.
Feb 20
8-K · 7.01
! Medium
Amrize Ltd -- 8-K 7.01: Regulation FD Disclosure
Amrize Ltd disclosed an investor presentation through an 8-K filing, indicating the company is proactively communicating its business strategy and financial information to shareholders and potential investors.
Feb 17
8-K · 5.02
!!! Very High
Amrize Ltd -- 8-K 5.02: Executive Change
Theresa Drew simultaneously resigned and was appointed as director at Amrize Ltd, suggesting a potential board restructuring or role change rather than a meaningful executive shift.
Feb 12
8-K
Amrize Ltd -- 8-K Filing
I cannot provide a meaningful investor summary for this filing, as the provided details contain only technical metadata and XBRL formatting references rather than substantive business information about Amrize Ltd.
Feb 9
Data updated apr 24, 2026 5:56pm
· Source: massive.com